Webinar: Emerging Trends and Challenges in AAV Manufacturing for Gene Therapies
Adeno-associated viral (AAV) vectors are the most prominent delivery vehicles being investigated for the treatment of genetic diseases. Although the successes of AAV-based gene therapies in pre-clinical and clinical studies are encouraging, limitations in vector characterization and manufacturing still pose significant challenges.
Here, a panel of experts in vector development and characterization discuss the emerging trends and future challenges of AAV-based gene therapies. They dive deeper into analytical methods used to characterize vector critical quality attributes (CQAs) and highlight crucial areas for improvement in AAV manufacturing.
You will learn about: